LEIDEBIO Co., Ltd. Is a scientific and technological innovation company focusing on " immunity" diagnostic system, a new generation of in vitro diagnostic technology. LEIDEBIO immune platform technology breaked through the limitations of modern molecular diagnostic technology. It realizes the accurate diagnosis and analysis of complex immune-related diseases, sunc as disease diagnosis, disease evaluation and medication guidance, early diagnosis and personality for clinical patients.

The company has development laboratory in Maryland, USA, and Medical Laboratory in Guangzhou. At present, it has more than 20 intellectual property rights. It is a national high-tech enterprise, a technological giant in Guangzhou and a post-doctoral innovation center.

Product lines:

(1) In vitro diagnostic reagents: Develop and produce specialized reagents for the diagnosis of immune-related diseases. At present, the products mainly focus on the clinical diagnosis of tuberculosis (TB), rheumatoid arthritis (RA) and cytokine storm (CRS) in the treatment of tumor immune cells.

(2) IVD testing raw materials: Flow pattern applied antibody and in vitro diagnostic target molecule, edited by genetic engineering technology, are highly correlated with the testing results of imported brands;

(3) Automation equipment: Develop fully automatic, portable and intelligent instruments and equipment with functions of sample collection, processing, detection and reporting, which are matched with diagnostic reagents for immune diseases;

(4) Primary immune cells (customized services): Standardized, ready-to-use, highly active primary immune cells, which can be used in pre-clinical drug research and development, immune cell function analysis and other scientific research;

(5) Medical diagnostic technology services: Specialized independent medical laboratories featuring immune diseases and immune function assessment provide professional, fast and accurate third-party detection and services for immune function analysis.